Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trade Wind Biotech is a Taiwan-based synthetic biology company developing engineered probiotic and microbial cell-factory technologies to produce high-value natural compounds, functional ingredients, and health-related products. The company is best known for its platform to biosynthesize natural astaxanthin and other rare natural products through fermentation rather than traditional agricultural or chemical extraction methods. Its business appears to span ingredient production, consumer wellness and skincare products, and enabling R&D services, with longer-term ambitions in natural pharmaceuticals, vaccines, and space-environment applications. Trade Wind Biotech is listed on Taiwan's emerging market ecosystem under ticker 7656 and remains an operating independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TW Trade.